Mars Resident Recognized for Excellence in Scholarship at DU
Dr. James Drennen III, associate dean of research and graduate programs in the Mylan School of Pharmacy/Graduate School of Pharmaceutical Sciences received the Duquesne University Presidential Award for Excellence in Scholarship.
Holder of the Noble J. Dick Endowed Chair in Academic Leadership, Drennen has focused his research on the manufacture and analysis of pharmaceuticals. He has pioneered the use of near-infrared spectroscopy to assess the quality of pharmaceuticals. The work of his team has attracted industrial contracts and collaboration with the U.S. Food and Drug Administration (FDA).
Drennen also serves as the lead faculty representative for Duquesne in the National Institute for Pharmaceutical Technology and Education, a nonprofit consortium of leading universities in pharmaceutical science and engineering. He has helped the group to attract a recent $35 million contract from the FDA. Drennen has provided a variety of training programs to the FDA with his graduate students and faculty colleagues. He is a noted expert among academic, industry and government circles.
The founder and chief editor of the peer-reviewed Journal of Pharmaceutical Innovation, Drennen is currently researching methods for monitoring and controlling pharmaceutical manufacturing processes.
Founded in 1878, Duquesne is consistently ranked among the nation's top Catholic universities for its award-winning faculty and tradition of academic excellence. Duquesne, a campus of nearly 9,500 graduate and undergraduate students, has been nationally recognized for its academic programs, community service and commitment to sustainability. Follow Duquesne University on Facebook, Twitter and Instagram.